These antiapoptotic mechanisms constitute vulnerabilities and, consequently, targeting them with either BCL2 family inhibitors 24,25,34 or via suppression of cFLIP 26 kills senescent cells
84 One feature relevant to clinical application is that linagliptin is cleared primarily via the hepatobiliary system, which has important implications for its use in patients with diabetic kidney disease, considering that linagliptin does not require dose reduction in patients with declining renal function
Not just reduce them slightly
Interest in glucagon-like peptide 1 receptor agonists (GLP-1s) continues to surge due to their effectiveness in reducing body weight and improving metabolic outcomes
Heres what were actually seeing in dental practices across the Austin area, what the current evidence says, and most importantly what you can do right now to protect your teeth if youre on one of these medications
Crucially, the dramatic weight loss induced by Retatrutide must be underpinned by a substantial reduction in adipose mass [16, 17]